Pharmacists in Keyser, West Virginia


13 Pharmacists found in Keyser
male pharmacist

Andrew D Herndon, PHARMD


Pharmacist
148 Walmart Dr, Keyser, WV 26726
304-788-8170     304-788-8172

male pharmacist

Dr. Brent Kiles Barrick, PHARM.D.


Pharmacist
Rr 3 Box 3186, Keyser, WV 26726
304-788-5931     304-788-9765

female pharmacist

Carrie Kitzmiller, PHARMD


Pharmacist
148 Walmart Dr, Keyser, WV 26726
304-788-8170    



female pharmacist

Cassie Lynch


Pharmacist
148 Walmart Dr, Keyser, WV 26726
304-788-8170    

male pharmacist

Mr. Christopher Alan Iames, RPH


Pharmacist
1405 Bonnie View Ter, Keyser, WV 26726
304-788-6010     304-788-5989

male pharmacist

Daniel Lewis, PHARMD


Pharmacist
45 S Mineral St, Keyser, WV 26726
304-788-3443    

male pharmacist

James Steven Oaks, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1405 Bonnie View Ter, Keyser, WV 26726
301-876-0985     304-788-5989

male pharmacist

Mr. Jarvis Mark Reed, RPH


Pharmacist
43 N Main St, Keyser, WV 26726
304-788-1643     304-788-0525

male pharmacist

Jeffrey Marshall Whitehead, RPH


Pharmacist
Rr 3 Box 3186, Keyser, WV 26726
304-788-5931    

male pharmacist

Justin Allen Winebrenner


Pharmacist
45 S Mineral St, Keyser, WV 26726
304-788-3443    

female pharmacist

Mrs. Marcella Ellen Hamric, RPH


Pharmacist
Rr 3 Box 3186, Keyser, WV 26726
304-788-5931     304-788-9765

female pharmacist

Ruby Ann Olitan, PHARMD


Pharmacist
Rr 3 3186, Keyser, WV 26726
304-788-5931    

male pharmacist

Ryan Cavender, PHARMD


Pharmacist
Rr 3 Box 3186, Keyser, WV 26726
304-788-5931    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.